An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Sophie Blein; Claire Bardel; Vincent Danjean; Lesley McGuffog; Sue Healey; Daniel Barrowdale; Andrew Lee; Joe Dennis; Karoline B Kuchenbaecker; Penny Soucy; Mary Beth Terry; Wendy K Chung; David E Goldgar; Saundra S Buys; Ramunas Janavicius; Laima Tihomirova; Nadine Tung; Cecilia M Dorfling; Elizabeth J van Rensburg; Susan L Neuhausen; Yuan Chun Ding; Anne-Marie Gerdes; Bent Ejlertsen; Finn C Nielsen; Thomas Vo Hansen; Ana Osorio; Javier Benitez; Raquel Andrés-Conejero; Ena Segota; Jeffrey N Weitzel; Margo Thelander; Paolo Peterlongo; Paolo Radice; Valeria Pensotti; Riccardo Dolcetti; Bernardo Bonanni; Bernard Peissel; Daniela Zaffaroni; Giulietta Scuvera; Siranoush Manoukian; Liliana Varesco; Gabriele L Capone; Laura Papi; Laura Ottini; Drakoulis Yannoukakos; Irene Konstantopoulou; Judy Garber; Ute Hamann; Alan Donaldson; Inge Sokilde Pedersen; BCFR

doi:10.1186/s13058-015-0567-2

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Sophie Blein, Claire Bardel, Vincent Danjean, Lesley McGuffog, Sue Healey, Daniel Barrowdale, Andrew Lee, Joe Dennis, Karoline B Kuchenbaecker, Penny Soucy, Mary Beth Terry, Wendy K Chung, David E Goldgar, Saundra S Buys, Ramunas Janavicius, Laima Tihomirova, Nadine Tung, Cecilia M Dorfling, Elizabeth J van Rensburg, Susan L NeuhausenYuan Chun Ding, Anne-Marie Gerdes, Bent Ejlertsen, Finn C Nielsen, Thomas Vo Hansen, Ana Osorio, Javier Benitez, Raquel Andrés-Conejero, Ena Segota, Jeffrey N Weitzel, Margo Thelander, Paolo Peterlongo, Paolo Radice, Valeria Pensotti, Riccardo Dolcetti, Bernardo Bonanni, Bernard Peissel, Daniela Zaffaroni, Giulietta Scuvera, Siranoush Manoukian, Liliana Varesco, Gabriele L Capone, Laura Papi, Laura Ottini, Drakoulis Yannoukakos, Irene Konstantopoulou, Judy Garber, Ute Hamann, Alan Donaldson, Inge Sokilde Pedersen, BCFR

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

30 Citationer (Scopus)

Abstract

INTRODUCTION: Individuals carrying pathogenic mutations in BRCA1/2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals from different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. Here we test the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers.

METHODS: We genotyped 22214 (11421 affected, 10793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched for affected or unaffected individuals.

RESULTS: We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers than the rest of clade T, (Hazard Ratio (HR) = 0.55 (95% Confidence Interval (CI) 0.34-0.88, p-value = 0.01). Compared with the most frequent haplogroup in the general population i.e. H and T clade, the T1a1 haplogroup has an HR = 0.62 (95% CI = 0.40-0.95, p-value = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk.

CONCLUSIONS: This study illustrates how original approaches like the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects.

Originalsprog	Engelsk
Artikelnummer	61
Tidsskrift	Breast Cancer Research (Online Edition)
Vol/bind	17
Udgave nummer	61
ISSN	1465-5411
DOI	https://doi.org/10.1186/s13058-015-0567-2
Status	Udgivet - 25 apr. 2015

Adgang til dokumentet

10.1186/s13058-015-0567-2

AUB Link

Søg efter materialet i Aalborg Universitetsbiblioteks søgemaskine

Citationsformater

Blein, S., Bardel, C., Danjean, V., McGuffog, L., Healey, S., Barrowdale, D., Lee, A., Dennis, J., Kuchenbaecker, K. B., Soucy, P., Terry, M. B., Chung, W. K., Goldgar, D. E., Buys, S. S., Janavicius, R., Tihomirova, L., Tung, N., Dorfling, C. M., van Rensburg, E. J., ... BCFR (2015). An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research (Online Edition), 17(61), Artikel 61. https://doi.org/10.1186/s13058-015-0567-2

@article{ded7c043ef7541aabfe6ac0004ff62ec,

title = "An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers",

abstract = "INTRODUCTION: Individuals carrying pathogenic mutations in BRCA1/2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals from different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. Here we test the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers.METHODS: We genotyped 22214 (11421 affected, 10793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched for affected or unaffected individuals.RESULTS: We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers than the rest of clade T, (Hazard Ratio (HR) = 0.55 (95% Confidence Interval (CI) 0.34-0.88, p-value = 0.01). Compared with the most frequent haplogroup in the general population i.e. H and T clade, the T1a1 haplogroup has an HR = 0.62 (95% CI = 0.40-0.95, p-value = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk.CONCLUSIONS: This study illustrates how original approaches like the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects.",

author = "Sophie Blein and Claire Bardel and Vincent Danjean and Lesley McGuffog and Sue Healey and Daniel Barrowdale and Andrew Lee and Joe Dennis and Kuchenbaecker, {Karoline B} and Penny Soucy and Terry, {Mary Beth} and Chung, {Wendy K} and Goldgar, {David E} and Buys, {Saundra S} and Ramunas Janavicius and Laima Tihomirova and Nadine Tung and Dorfling, {Cecilia M} and {van Rensburg}, {Elizabeth J} and Neuhausen, {Susan L} and Ding, {Yuan Chun} and Anne-Marie Gerdes and Bent Ejlertsen and Nielsen, {Finn C} and Hansen, {Thomas Vo} and Ana Osorio and Javier Benitez and Raquel Andr{\'e}s-Conejero and Ena Segota and Weitzel, {Jeffrey N} and Margo Thelander and Paolo Peterlongo and Paolo Radice and Valeria Pensotti and Riccardo Dolcetti and Bernardo Bonanni and Bernard Peissel and Daniela Zaffaroni and Giulietta Scuvera and Siranoush Manoukian and Liliana Varesco and Capone, {Gabriele L} and Laura Papi and Laura Ottini and Drakoulis Yannoukakos and Irene Konstantopoulou and Judy Garber and Ute Hamann and Alan Donaldson and Pedersen, {Inge Sokilde} and BCFR",

year = "2015",

month = apr,

day = "25",

doi = "10.1186/s13058-015-0567-2",

language = "English",

volume = "17",

journal = "Breast Cancer Research (Online Edition)",

issn = "1465-5411",

publisher = "BioMed Central",

number = "61",

}

Blein, S, Bardel, C, Danjean, V, McGuffog, L, Healey, S, Barrowdale, D, Lee, A, Dennis, J, Kuchenbaecker, KB, Soucy, P, Terry, MB, Chung, WK, Goldgar, DE, Buys, SS, Janavicius, R, Tihomirova, L, Tung, N, Dorfling, CM, van Rensburg, EJ, Neuhausen, SL, Ding, YC, Gerdes, A-M, Ejlertsen, B, Nielsen, FC, Hansen, TV, Osorio, A, Benitez, J, Andrés-Conejero, R, Segota, E, Weitzel, JN, Thelander, M, Peterlongo, P, Radice, P, Pensotti, V, Dolcetti, R, Bonanni, B, Peissel, B, Zaffaroni, D, Scuvera, G, Manoukian, S, Varesco, L, Capone, GL, Papi, L, Ottini, L, Yannoukakos, D, Konstantopoulou, I, Garber, J, Hamann, U, Donaldson, A, Pedersen, IS & BCFR 2015, 'An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers', Breast Cancer Research (Online Edition), bind 17, nr. 61, 61. https://doi.org/10.1186/s13058-015-0567-2

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. / Blein, Sophie; Bardel, Claire; Danjean, Vincent et al.
I: Breast Cancer Research (Online Edition), Bind 17, Nr. 61, 61, 25.04.2015.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

TY - JOUR

T1 - An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

AU - Blein, Sophie

AU - Bardel, Claire

AU - Danjean, Vincent

AU - McGuffog, Lesley

AU - Healey, Sue

AU - Barrowdale, Daniel

AU - Lee, Andrew

AU - Dennis, Joe

AU - Kuchenbaecker, Karoline B

AU - Soucy, Penny

AU - Terry, Mary Beth

AU - Chung, Wendy K

AU - Goldgar, David E

AU - Buys, Saundra S

AU - Janavicius, Ramunas

AU - Tihomirova, Laima

AU - Tung, Nadine

AU - Dorfling, Cecilia M

AU - van Rensburg, Elizabeth J

AU - Neuhausen, Susan L

AU - Ding, Yuan Chun

AU - Gerdes, Anne-Marie

AU - Ejlertsen, Bent

AU - Nielsen, Finn C

AU - Hansen, Thomas Vo

AU - Osorio, Ana

AU - Benitez, Javier

AU - Andrés-Conejero, Raquel

AU - Segota, Ena

AU - Weitzel, Jeffrey N

AU - Thelander, Margo

AU - Peterlongo, Paolo

AU - Radice, Paolo

AU - Pensotti, Valeria

AU - Dolcetti, Riccardo

AU - Bonanni, Bernardo

AU - Peissel, Bernard

AU - Zaffaroni, Daniela

AU - Scuvera, Giulietta

AU - Manoukian, Siranoush

AU - Varesco, Liliana

AU - Capone, Gabriele L

AU - Papi, Laura

AU - Ottini, Laura

AU - Yannoukakos, Drakoulis

AU - Konstantopoulou, Irene

AU - Garber, Judy

AU - Hamann, Ute

AU - Donaldson, Alan

AU - Pedersen, Inge Sokilde

AU - BCFR

PY - 2015/4/25

Y1 - 2015/4/25

N2 - INTRODUCTION: Individuals carrying pathogenic mutations in BRCA1/2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals from different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. Here we test the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers.METHODS: We genotyped 22214 (11421 affected, 10793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched for affected or unaffected individuals.RESULTS: We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers than the rest of clade T, (Hazard Ratio (HR) = 0.55 (95% Confidence Interval (CI) 0.34-0.88, p-value = 0.01). Compared with the most frequent haplogroup in the general population i.e. H and T clade, the T1a1 haplogroup has an HR = 0.62 (95% CI = 0.40-0.95, p-value = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk.CONCLUSIONS: This study illustrates how original approaches like the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects.

AB - INTRODUCTION: Individuals carrying pathogenic mutations in BRCA1/2 genes have a high lifetime risk of breast cancer. BRCA1 and BRCA2 are involved in DNA double strand break repair, DNA alterations that can be caused by exposure to reactive oxygen species, a main source of which are mitochondria. Mitochondrial genome variations affect electron transport chain efficiency and reactive oxygen species production. Individuals from different mitochondrial haplogroups differ in their metabolism and sensitivity to oxidative stress. Variability in mitochondrial genetic background can alter reactive oxygen species production, leading to cancer risk. Here we test the hypothesis that mitochondrial haplogroups modify breast cancer risk in BRCA1/2 mutation carriers.METHODS: We genotyped 22214 (11421 affected, 10793 unaffected) mutation carriers belonging to the Consortium of Investigators of Modifiers of BRCA1/2 for 129 mitochondrial polymorphisms using the iCOGS array. Haplogroup inference and association detection were performed using a phylogenetic approach. ALTree was applied to explore the reference mitochondrial evolutionary tree and detect subclades enriched for affected or unaffected individuals.RESULTS: We discovered that subclade T1a1 was depleted in affected BRCA2 mutation carriers than the rest of clade T, (Hazard Ratio (HR) = 0.55 (95% Confidence Interval (CI) 0.34-0.88, p-value = 0.01). Compared with the most frequent haplogroup in the general population i.e. H and T clade, the T1a1 haplogroup has an HR = 0.62 (95% CI = 0.40-0.95, p-value = 0.03). We also identified three potential susceptibility loci, including G13708A/rs28359178, which has demonstrated an inverse association with familial breast cancer risk.CONCLUSIONS: This study illustrates how original approaches like the phylogeny-based method we used can empower classical molecular epidemiological studies aimed at identifying association or risk modification effects.

U2 - 10.1186/s13058-015-0567-2

DO - 10.1186/s13058-015-0567-2

M3 - Journal article

C2 - 25925750

SN - 1465-5411

VL - 17

JO - Breast Cancer Research (Online Edition)

JF - Breast Cancer Research (Online Edition)

IS - 61

M1 - 61

ER -

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

Abstract

Adgang til dokumentet

AUB Link

Fingeraftryk

Citationsformater